Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for Raf inhibitors

Details for Australian Patent Application No. 2007340265 (hide)

Owner Novartis AG

Inventors Stuart, Darrin; Moler, Edward; Aardalen, Kim; Heise, Carla; Aziz, Natasha

Agent Davies Collison Cave

Pub. Number AU-B-2007340265

PCT Pub. Number WO2008/082730

Priority 60/845,601 19.09.06 US

Filing date 19 September 2007

Wipo publication date 10 July 2008

Acceptance publication date 26 July 2012

International Classifications

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/082730 Priority application(s): WO2008/082730

26 July 2012 Application Accepted

  Published as AU-B-2007340265

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007340272-Spine stiffening device and associated method

2007340263-Sterilization indicator